XML 11 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Balance Sheet (Unaudited)
Sep. 30, 2020
USD ($)
ASSETS  
Current asset - cash $ 55,373
Deferred offering costs 329,461
TOTAL ASSETS 384,834
Current liabilities  
Accrued offering costs 76,472
Promissory note - related party 289,104
Total Liabilities 365,576
Commitments
Shareholder’s Equity  
Preference shares, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding
Additional paid-in capital 23,419
Accumulated deficit (5,742)
Total Shareholder’s Equity 19,258
TOTAL LIABILITIES AND SHAREHOLDER’S EQUITY 384,834
Class A ordinary shares  
Shareholder’s Equity  
Ordinary shares value
Class B ordinary shares  
Shareholder’s Equity  
Ordinary shares value 1,581 [1]
Total Shareholder’s Equity $ 1,581
[1] As of September 30, 2020, included an aggregate of up to 2,062,500 Class B ordinary shares subject to forfeiture if the over-allotment was not exercised in full or in part by the underwriters (see Note 4). On July 20, 2020, the Company declared a share dividend of one share for each Class B ordinary share in issue, on September 22, 2020, the Company effected a share dividend of 1.5 shares for each Class B ordinary share in issue, and on October 13, 2020, the Company effected a share dividend of 0.1 shares for each Class B ordinary share in issue, resulting in an aggregate of 15,812,500 Founder Shares issued and outstanding (see Note 4). All share and per-share amounts have been retroactively restated to reflect the share dividends.